242 related articles for article (PubMed ID: 10873574)
1. Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure.
Kamohara Y; Sugiyama N; Mizuguchi T; Inderbitzin D; Lilja H; Middleton Y; Neuman T; Demetriou AA; Rozga J
Biochem Biophys Res Commun; 2000 Jun; 273(1):129-35. PubMed ID: 10873574
[TBL] [Abstract][Full Text] [Related]
2. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of a new STAT-induced STAT inhibitor.
Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity.
Gao C; Jokerst R; Gondipalli P; Cai SR; Kennedy S; Flye MW; Ponder KP
Hepatology; 1999 Dec; 30(6):1405-16. PubMed ID: 10573519
[TBL] [Abstract][Full Text] [Related]
5. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
Chen T; Wang LH; Farrar WL
Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.
Leu JI; Crissey MA; Leu JP; Ciliberto G; Taub R
Mol Cell Biol; 2001 Jan; 21(2):414-24. PubMed ID: 11134330
[TBL] [Abstract][Full Text] [Related]
8. Regulation of c-met expression in rats with acute hepatic failure.
Mizuguchi T; Kamohara Y; Hui T; Neuman T; Mitaka T; Demetriou AA; Rozga J
J Surg Res; 2001 Aug; 99(2):385-96. PubMed ID: 11469916
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
11. Knocking the SOCS off a tumor suppressor.
Kishimoto T; Kikutani H
Nat Genet; 2001 May; 28(1):4-5. PubMed ID: 11326261
[No Abstract] [Full Text] [Related]
12. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
13. Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3).
Magrangeas F; Boisteau O; Denis S; Jacques Y; Minvielle S
Biochem J; 2001 Jan; 353(Pt 2):223-30. PubMed ID: 11139384
[TBL] [Abstract][Full Text] [Related]
14. Ethanol rapidly inhibits IL-6-activated STAT3 and C/EBP mRNA expression in freshly isolated rat hepatocytes.
Chen J; Kunos G; Gao B
FEBS Lett; 1999 Aug; 457(1):162-8. PubMed ID: 10486586
[TBL] [Abstract][Full Text] [Related]
15. In vivo activation of the interleukin-6 receptor/gp130 signaling pathway in pituitary corticotropes of lipopolysaccharide-treated rats.
Gautron L; Lafon P; Tramu G; Layé S
Neuroendocrinology; 2003 Jan; 77(1):32-43. PubMed ID: 12624539
[TBL] [Abstract][Full Text] [Related]
16. What are appropriate controls for cardiac interleukin-6 expression in heart failure?
Plenz GA; Eschert H; Deng MC
Circulation; 2003 Oct; 108(17):e129-30; author reply e129-30. PubMed ID: 14581394
[No Abstract] [Full Text] [Related]
17. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
18. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
19. Activation of signal transducer and activator transcription 3 and expression of suppressor of cytokine signal 1 during liver regeneration in rats.
Sakuda S; Tamura S; Yamada A; Miyagawa Ji; Yamamoto K; Kiso S; Ito N; Imanaka K; Wada A; Naka T; Kishimoto T; Kawata S; Matsuzawa Y
J Hepatol; 2002 Mar; 36(3):378-84. PubMed ID: 11867182
[TBL] [Abstract][Full Text] [Related]
20. LIF-induced STAT3 signaling in murine versus human embryonal carcinoma (EC) cells.
Schuringa JJ; van der Schaaf S; Vellenga E; Eggen BJ; Kruijer W
Exp Cell Res; 2002 Mar; 274(1):119-29. PubMed ID: 11855863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
